VistaGen Financial Statements From 2010 to 2026

VistaGen Therapeutics Balance Sheet		Trends
Current Value Last Year Historical Average  10 Year Trend Total Assets 101.8 M 97 M 38.1 M Slightly volatile Total Current Liabilities 15.2 M 14.5 M 5.9 M Slightly volatile Accounts Payable 1.3 M 751 K 1.4 M Very volatile Common Stock Total Equity 249.6 K 237.7 K 100.1 K Slightly volatile Common Stock Shares Outstanding 37.1 M 35.3 M 8.4 M Slightly volatile Liabilities And Stockholders Equity 101.8 M 97 M 38.1 M Slightly volatile Other Stockholder Equity 577.2 M 549.7 M 252 M Slightly volatile Total Liabilities 8.7 M 16 M 9.8 M Slightly volatile Total Current Assets 99.1 M 94.4 M 36.5 M Slightly volatile Common Stock 29 K 33.4 K 30.6 K Pretty Stable Short and Long Term Debt Total 2.2 M 1.4 M 3 M Pretty Stable Property Plant And Equipment Net 1.2 M 2.1 M 1.3 M Slightly volatile Non Current Assets Total 1.5 M 2.6 M 1.6 M Slightly volatile Non Current Liabilities Total 1.5 M 1.5 M 4.4 M Pretty Stable Property Plant And Equipment Gross 3.9 M 3.7 M 1.8 M Slightly volatile Short Term Debt 971.2 K 504.9 K 1.3 M Pretty Stable Other Current Liabilities 10.6 M 10.1 M 2.6 M Slightly volatile Other Liabilities 1.5 M 2.1 M 1.9 M Very volatile Current Deferred Revenue 3.1 M 3 M 1.4 M Slightly volatile Non Currrent Assets Other 305.3 K 522.1 K 279 K Slightly volatile Other Assets 983.1 K 936.3 K 370.8 K Slightly volatile Long Term Debt 7.7 K 8.1 K 840.6 K Slightly volatile Net Receivables 733 K 923.1 K 506.4 K Slightly volatile Other Current Assets 1.9 M 1.8 M 600.7 K Slightly volatile Property Plant Equipment 3.3 M 3.2 M 1.4 M Slightly volatile Long Term Debt Total 2.6 K 2.7 K 4.9 K Very volatile Capital Surpluse 214.3 M 386.5 M 202.3 M Slightly volatile Capital Lease Obligations 1.9 M 1.7 M 1.2 M Slightly volatile Short and Long Term Debt 90 K 94.8 K 2.9 M Slightly volatile Non Current Liabilities Other 4.9 M 4.8 M 4.2 M Slightly volatile Capital Stock 24.8 K 26.1 K 57.7 K Very volatile Deferred Long Term Asset Charges 187.3 K 210.7 K 230 K Slightly volatile
VistaGen Therapeutics Income Statement		Trends
Current Value Last Year Historical Average  10 Year Trend Selling General Administrative 20.6 M 19.6 M 9.3 M Slightly volatile Other Operating Expenses 68.2 M 64.9 M 27.5 M Slightly volatile Total Operating Expenses 68.2 M 64.9 M 27.5 M Slightly volatile Depreciation And Amortization 766.8 K 730.2 K 293.9 K Slightly volatile Selling And Marketing Expenses 1.6 M 1.7 M 293.9 B Slightly volatile Research Development 47.5 M 45.3 M 18.3 M Slightly volatile Tax Provision 8.5 K 8.1 K 3.8 K Slightly volatile Reconciled Depreciation 390.2 K 730.2 K 266.1 K Slightly volatile Preferred Stock And Other Adjustments 756.1 K 850.6 K 928.4 K Slightly volatile
VistaGen Therapeutics Cash Flow Statement		Trends
Current Value Last Year Historical Average  10 Year Trend End Period Cash Flow 81.1 M 77.2 M 33 M Slightly volatile Begin Period Cash Flow 143.9 M 137 M 36.3 M Slightly volatile Other Cashflows From Financing Activities 219.6 K 231.2 K 257.4 M Very volatile Depreciation 766.8 K 730.2 K 272.7 K Slightly volatile Stock Based Compensation 2.9 M 5 M 2.7 M Slightly volatile Change To Netincome 3 M 3.1 M 5.4 M Pretty Stable Issuance Of Capital Stock 3.3 M 3.5 M 24.1 M Pretty Stable
Financial Ratios		Trends
Current Value Last Year Historical Average  10 Year Trend Dividend Yield 4.21 4.43 43.3865 Slightly volatile Capex To Depreciation 37.45 35.6667 5.1898 Slightly volatile Inventory Turnover 0.32 0.36 0.3893 Slightly volatile Days Of Inventory On Hand 738 830 906 Slightly volatile Payables Turnover 0.0534 0.0505 0.0591 Pretty Stable Days Payables Outstanding 6.2 K 7.5 K 6.2 K Pretty Stable Income Quality 0.52 0.7663 0.5884 Slightly volatile Current Ratio 0.54 0.565 5.2092 Slightly volatile Capex Per Share 0.0703 0.074 0.5767 Slightly volatile Interest Debt Per Share 0.0258 0.0272 77.4538 Slightly volatile Debt To Assets 0.23 0.2409 6.3118 Slightly volatile Days Of Payables Outstanding 6.2 K 7.5 K 6.2 K Pretty Stable Ebt Per Ebit 1.36 1.06 1.2446 Slightly volatile Quick Ratio 0.54 0.565 5.204 Slightly volatile Net Income Per E B T 0.8 1.0034 0.9886 Slightly volatile Days Of Inventory Outstanding 738 830 906 Slightly volatile Free Cash Flow Operating Cash Flow Ratio 1.12 1.089 1.0228 Slightly volatile Debt Ratio 0.23 0.2409 6.3118 Slightly volatile
VistaGen Therapeutics Valuation Data		Trends
Current Value Last Year Historical Average  10 Year Trend Market Cap 21.4 M 22.5 M 42.7 M Pretty Stable Enterprise Value 9.5 M 10 M 27.6 M Pretty Stable

VistaGen Fundamental Market Drivers

VistaGen Upcoming Events

About VistaGen Therapeutics Financial Statements

Pair Trading with VistaGen Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if VistaGen Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in VistaGen Therapeutics will appreciate offsetting losses from the drop in the long position's value.When determining whether VistaGen Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VistaGen Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vistagen Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vistagen Therapeutics Stock:

How To Invest In VistaGen Details

Is VistaGen Stock a good investment? Details

What is VistaGen Therapeutics' Net Worth? Details

Largest Biotechnology Companies View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies View

Altman Z Score Details

Piotroski F Score Details

Beneish M Score Details

Financial Analysis Details

Buy or Sell Advice Details

Earnings Projections Details